Triple synchronous primary gynaecological tumours. A case report  by Gutiérrez-Palomino, Laura et al.
Cirugía y Cirujanos. 2016;84(1):69--72
www.amc.org.mx www.elsevier.es/circir
CIRUGÍA  y  CIRUJANOS
Órgano de difusión científica de la Academia Mexicana de Cirugía
Fundada en 1933
CLINICAL CASE
Triple  synchronous  primary  gynaecological  tumours.
A case  report
Laura Gutiérrez-Palominoa,∗, José María Romo-de los Reyesa,
María  Jesús Pareja-Megíab, José Antonio García-Mejidoa
a Servicio  de  Ginecología  y  Obstetricia,  Hospital  Universitario  Virgen  de  Valme,  Sevilla,  Spain
b Servicio  de  Anatomía  Patológica,  Hospital  Universitario  Virgen  de  Valme,  Sevilla,  Spain
Received 15  May  2014;  accepted  3  November  2014
Available  online  11  February  2016
KEYWORDS
Ovarian  cancer;
Endometrial  cancer;
Fallopian  tube
cancer;
Synchronous  cancers;
Multiple  synchronous
cancers
Abstract
Background:  Synchronous  multiple  primary  malignancies  in  the  female  genital  tract  are  infre-
quent. From  50  to  70%  of  them  corresponds  to  synchronous  cancers  of  the  endometrium  and
ovary. To  our  knowledge,  this  is  only  the  third  case  report  in  the  international  literature  of
three concurrent  gynaecological  cancers  of  epithelial  origin.  A  case  is  presented,  as  well  as
a literature  review  due  to  the  infrequency  of  its  diagnosis  and  the  lack  of  information  on  the
subject.
Clinical case:  A  49-year-old  woman,  with  previous  gynaecological  history  of  ovarian
endometriosis.  She  underwent  a  hysterectomy  and  bilateral  oophorectomy,  as  she  had  been
diagnosed with  endometrial  hyperplasia  with  atypia.  The  ﬁnal  histopathology  reported  syn-
chronous  ovarian,  Fallopian  tube,  and  endometrial  cancer.  An  extension  study  and  complete
surgical staging  was  performed,  both  being  negative.  She  received  adjuvant  treatment  of
chemotherapy  and  radiotherapy.  She  is  currently  free  of  disease.
Conclusions:  The  aetiology  is  uncertain.  There  is  controversy  relating  to  increased  susceptibility
of synchronous  neoplasms  to  pelvic  endometriosis  and  inherited  genetic  syndromes.  Its  diagnosis
needs to  differentiate  them  from  metastatic  disease.  Additionally,  they  are  problematical  from
a clinical,  diagnostic,  therapeutic,  and  prognostic  point  of  view.  The  presentation  of  more  cases
of triple  synchronous  cancers  is  necessary  for  a  complete  adjuvant  and  surgical  treatment.
© 2015  Academia  Mexicana  de  Cirugía  A.C.  Published  by  Masson  Doyma  México  S.A.  This  is
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Tumores  triple  sincrónicos  ginecológicos.  Reporte  de  un  caso
Resumen
Antecedentes:  El  desarrollo  sincrónico  de  múltiples  tumores  en  el  tracto  genital  femenino  es
infrecuente.  Del  50%  al  70%  lo  constituyen  el  grupo  de  neoplasias  sincrónicas  de  endometrio
y ovario.  Para  nuestro  conocimiento  este  es  el  tercer  caso  de  cáncer  triple  sincrónico
ginecológico,  de  la  bibliografía  médica  internacional.  Nos  proponemos  exponer  un  caso  de  nues-
tra unidad  y  hacer  una  revisión  de  la  bibliografía  médica  de  esta  entidad,  dada  la  infrecuencia
de su  diagnóstico  y  la  escasa  información  al  respecto.
Caso  clínico: Mujer  de  49  an˜os  de  edad,  con  historia  ginecológica  de  endometriosis  ovárica.  Se
le realizó  histerectomía  y  anexectomía  bilateral,  por  diagnóstico  de  hiperplasia  endometrial  con
atipias. La  anatomía  patológica  deﬁnitiva  informó  de  neoplasias  sincrónicas  de  ovario,  trompa
y, endometrio.  Se  realizó  estudio  de  extensión  y  se  sometió  a  la  paciente  a  cirugía  de  esta-
diﬁcación  completa,  siendo  negativas.  Se  administró  quimioterapia  y  radioterapia  adyuvantes.
Actualmente  se  encuentra  libre  de  enfermedad.
Conclusiones:  La  etiología  es  incierta.  Existe  controversia  acerca  de  una  mayor  predisposición
de las  neoplasias  sincrónicas  a  la  endometriosis  pélvica  y  a  los  síndromes  genéticos  hereditarios.
En su  diagnóstico  es  necesario  diferenciarlas  de  la  enfermedad  metastásica.  Además  plantean
problemas  desde  el  punto  de  vista  clínico,  diagnóstico,  terapéutico  y  pronóstico.  Es  necesaria
la presentación  de  más  casos  de  neoplasias  triple  sincrónicas  para  un  tratamiento  quirúrgico  y
adyuvante completo.
© 2015  Academia  Mexicana  de  Cirugía  A.C.  Publicado  por  Masson  Doyma  México  S.A.  Este  es
un artículo  Open  Access  bajo  la  licencia  CC  BY-NC-ND  (http://creativecommons.org/licenses/
by-nc-nd/4.0/).
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alignancies  which  occur  in  one  single  subject,  simulta-
eously  or  successively  are  termed  multiple  primary  or
ynchronous  tumours,  provided  they  meet  the  outlined
riteria1 (Table  1).
Synchronous  tumours  affect  less  than  1--2%  of  patients
ffected  by  cancers  of  the  endometrium  and  ovary.  The
revalence  in  epithelial  cancer  of  the  ovary  corresponds
o  10%,  whereas  in  the  case  of  adenocarcinoma  of  the
ndometrium  it  corresponds  to  5%.2 Tubular  adenocarcino-
as  have  an  incidence  of  1%,  most  often  being  diagnosed
Table  1  Diagnostic  criteria  of  synchronous  tumours.
Each  tumour  should  have  a  deﬁned  pattern  of  malignancy
It should  be  ruled  out  that  one  is  not  the  metastasis  of  the
other
Each tumour  presents  a  different  histology,  and  if  both  are
similar  inside  the  same  organ,  it  should  be  ensured  that  no
connection  between  them  can  be  demonstrated.
Each  tumour  should  follow  its  natural  history  and  might
develop  independently
Each  tumour  might  present  with  its  own  symptoms  or  be  a
ﬁnding  during  the  study  required  for  diagnosis,  staging  or
follow-up  of  the  ﬁrst,  or  even  only  be  found  post  mortem,
during autopsy
Diagnosis  of  the  tumours  can  be  successivea or
simultaneousb
a Metachronous.
b Synchronous.
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hey  generally  occur  in  young,  obese,  nulliparous  and  pre-
enopausal  women,  associated  with  hypoestrogenism.3 The
verage  age  of  diagnosis  is  between  the  fourth  and  ﬁfth
ecades  of  life.3,4 Some  authors  have  described  an  asso-
iation  of  double  and  triple  synchronous  tumours  with
ereditary  genetic  mutations,  such  as  Lynch  syndrome.5
linical case
 49  year  old  woman,  ex  smoker,  nulliparous,  with  a  gynae-
ological  history  of  ovarian  endometriosis  and  a  family
istory  of  paternal  digestive  tract  tumour  and  a  maternal
unt  with  breast  cancer.  An  endometrial  aspiration  biopsy
as  performed  for  metrorrhagia.  The  anatomopathologi-
al  diagnosis  was  endometrial  hyperplasia  with  atypias.
 scheduled  hysterectomy  was  performed  and  bilateral
dnexectomy.  Final  histopathology  reported  synchronous
varian,  right  Fallopian  tube,  and  endometrial  cancer  over
xtensive  areas  of  ovarian  endometriosis  and  myometrial
denomyosis.  No  pathological  ﬁndings  were  reported  in  the
vary  and  contralateral  Fallopian  tube.  The  3  malignan-
ies  were  visualised  without  direct  connection  between
hem,  with  a  different  degree  of  inﬁltration.  FIGO  classi-
cation  of  each  of  the  malignancies  was  adenocarcinoma
f  endometrium  T1CG2,  endometrioid  carcinoma  of  the
vary  T1A,  and  endometrioid  adenocarcinoma  of  the  Fal-
opian  tube  T1A.  Immunohistochemistry  revealed  the  same
roﬁle  for  the  3  malignancies:  the  presence  of  positive
estrogen  and  progesterone  receptors,  p53  negative  and
K7  positive.  Thoraco-abdominal  computed  tomography  was
Triple  synchronous  primary  gynaecological  tumours  
Figure  1  Macroscopic  image  of  synchronous  triple  tumour:
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requested,  with  no  evidence  of  distant  disease,  and  the
patient  underwent  full  staging  surgery,  including:  peritoneal
lavage,  omentectomy,  appendicectomy,  pelvic  and  paraortic
lymphadenectomy.  Four  and  5  lymph  nodes  were  obtained
in  the  right  and  left  lymph  node  chains,  respectively.  At
retroperitoneal  level  2  lymph  nodes  were  obtained,  the
anatomopathological  study  for  both  was  negative.  The
patient  received  adjuvant  chemotherapy  treatment  (taxol
and  cisplatin)  and  radiotherapy  under  oncological  criteria,
given  the  FIGO  stage  T1C  G2  present  in  the  endometrioid
adenocarcinoma,  with  the  objective  of  reducing  the  possi-
bility  of  relapse  (Fig.  1).
Discussion
The  aetiology  of  synchronous  tumours  is  uncertain.  Lauch-
lan  proposed  the  extended  müllerian  system,  which  covers
the  epithelium  from  the  ovarian  surface,  Fallopian  tubes  and
uterus  (neck  and  cervix)  as  a  single  morphological  unit.6 Var-
ious  authors  a  posteriori  explained  the  possible  presence  of
receptors  in  this  müllerian  system  which  would  respond  to
carcinogens  or  hormonal  factors.4,7 this  would  explain  syn-
chronous  tumours  of  a  similar  aetiology,  but  not  those  of  a
different  aetiology.
The  patients  are  classically  young,  obese,  nulliparous
and  premenopausal,3 like  the  patient  presented.  There  is
controversy  in  medical  literature  regarding  the  association
of  a  greater  predisposition  for  synchronous  malignancies
with  pelvic  endometriosis.2,8,9 Some  authors  argue  the
use  of  combined  hormonal  contraception  in  patients  with
endometriosis  as  a  chemopreventive  factor  against  gynae-
10cological  synchronous  malignancies.
Synchronous  carcinomas  of  the  endometrium  and  ovary
pose  various  problems  from  a  clinical,  diagnostic,  thera-
peutic  and  prognostic  perspective;  therefore  a  differential71
iagnosis  with  metastatic  disease  is  of  crucial  importance.  In
avour  of  the  presence  of  ovarian  metastasis  are:  the  small
ize  of  the  ovarian  lesion,  bilateral  involvement,  pattern  of
ultinodular  growth,  the  presence  of  associated  superﬁcial
mplants,  and  prominent  vascular  lymphatic  embolisation  of
he  stroma  of  the  ovary.1,11 Other  methods  which  help  us  to
ifferentiate  synchronous  tumours  from  metastatic  tumours
re:  molecular  studies,  the  presence  of  micro-satellites,
ow  cytometry  or  PTEN  oncogene  mutation12; although  as
et  there  is  no  consensus  amongst  anatomopathologists  as
o  their  usefulness.13
Immunohistochemistry  is  of  little  value  in  differentia-
ion,  as  both  endometrioid  carcinomas  of  the  ovary  and  the
terus,  primary  and  metastatic,  have  similar  immunopheno-
ypical  characteristics.9
According  to  Dragoumis  et  al.14 in  their  review,  treat-
ent  should  be  appropriate  for  both  tumours,  taking  into
onsideration  that  the  treatment  of  one  tumour  can  lead
o  incomplete  treatment  of  the  other.  Generally  treatment
ith  adjuvant  chemotherapy  with  or  without  association
ith  radiotherapy  is  the  most  used.
Synchronous  tumours  of  the  ovary  and  endometrium
re  tumours  with  a  good  prognosis,  especially  in  the
arly  stages.  Survival  at  5  years  is  85.9%  and  at  10
ears  is  80.3%.4,15,16 Survival  depends  on  the  FIGO  stage,
he  tumour’s  histology,  and  the  association  with  adjuvant
reatment.5,15 Relapse  varies  according  to  the  different
uthors  at  around  15.1%4,15 or  34%5 at  5  years.
From  an  anatomopathological  perspective  these  are
umours  of  difﬁcult  differential  diagnosis  with  metasta-
is,  with  different  therapeutic  and  prognostic  implications.
tudies  which  enable  a  differential  diagnosis  of  both  are
ecessary.  In  general,  these  are  tumours  with  a  good  progno-
is,  as  most  are  diagnosed  in  early  stages  and  endometrioid
istology  predominates.
onclusions
e  have  only  found  2  cases  in  medical  literature  on  triple
ynchronous  tumours  of  the  ovary,  endometrium  and  Fal-
opian  tube,  and  therefore  we  consider  that  publishing  this
ase  is  highly  relevant.  We  do  not  know  whether  the  progno-
is  and  treatment  are  comparable  to  synchronous  tumours
f  the  ovary  and  endometrium,  or  conversely,  whether  they
re  more  aggressive.
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